ArticleCancers2022

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB.

Ji Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.